. [J]. Asian Journal of Urology, 2023, 10(3): 213-214.
Guohua Zeng,Wei Zhu. Urolithiasis: From pathogenesis to management (part one). Asian Journal of Urology, 2023, 10(3): 213-214.
Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int 2017; 120:109-16.
doi: 10.1111/bju.13828
pmid: 28236332
[2]
Zhu W, Liu Y, Lan Y, Li X, Luo L, Duan X, et al. Dietary vinegar prevents kidney stone recurrence via epigenetic regulations. EBioMedicine 2019; 45:231-50.
doi: S2352-3964(19)30379-2
pmid: 31202812
[3]
Sarica K. Medical aspect and minimal invasive treatment of urinary stones in children. Arch Ital Urol Androl 2008; 80:43-9.
[4]
Traxer O, Keller EX. Thulium fiber laser: the new player for kidney stone treatment? A comparison with Holmium:YAG laser. World J Urol 2020; 38:1883-94.
doi: 10.1007/s00345-019-02654-5
pmid: 30729311
[5]
Jahrreiss V, Veser J, Seitz C, ? zsoy M. Artificial intelligence: the future of urinary stone management? Curr Opin Urol 2020; 30:196-9.
doi: 10.1097/MOU.0000000000000707
pmid: 31895075
[6]
Khan SR. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol 2013; 189: 803-11.
doi: 10.1016/j.juro.2012.05.078
pmid: 23022011
[7]
Liu CJ, Tsai YS, Huang HS. Atorvastatin decreases renal calcium oxalate stone deposits by enhancing renal osteopontin expression in hyperoxaluric stone-forming rats fed a high-fat diet. Int J Mol Sci 2022; 23:3048. https://doi.org/10.3390/ijms23063048.
doi: 10.3390/ijms23063048
[8]
Toblli JE, Ferder L, Stella I, Angerosa M, Inserra F. Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 2001; 166:275-80.
pmid: 11435885